Animal drug compounding market to reach $2.58 billion by 2030

By AI, Created 11:12 AM UTC, May 20, 2026, /AGP/ – The animal drug compounding market is projected to grow from $1.79 billion in 2025 to $1.91 billion in 2026, with North America holding the largest share. Rising pet spending, personalized veterinary care and new technologies are expected to keep demand climbing through 2030.

Why it matters: - Animal drug compounding supports customized veterinary treatments when standard medicines do not meet an animal’s needs. - The market’s projected growth signals rising demand for personalized care across companion animals and livestock. - Expanding pet ownership costs are helping drive more spending on tailored veterinary medications.

What happened: - The Business Research Company published its Animal Drug Compounding Market Report 2026 on May 4, 2026. - The market is projected to rise from $1.79 billion in 2025 to $1.91 billion in 2026, a 7.0% CAGR. - The report forecasts the market will reach $2.58 billion by 2030, implying a 7.8% CAGR. - The report covers global market trends, regional performance and forecast data through 2035. - North America held the largest share of the market in 2025.

The details: - Animal drug compounding combines and modifies ingredients from multiple medicines to create customized formulations for individual animals or groups. - The report cites rising chronic disease in companion animals, more veterinary visits, demand for customizable dosage forms, pet population growth and expansion among veterinary pharmaceutical companies as near-term growth drivers. - Future growth is expected to come from compounding technology improvements, greater use of artificial intelligence to tailor treatments, broader use in livestock health, stronger awareness of personalized veterinary therapy and integration with diagnostic tools. - Key trends include stronger demand for custom veterinary medications, more injectable and oral compounded products, and increased focus on companion animal wellness. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The full report is available here, and a free sample is available here. - Related reports include Farm Animal Drugs Global Market Report 2026, Companion Animal Pharmaceuticals Global Market Report 2026 and Animal Medicine Global Market Report 2026.

Between the lines: - Rising pet spending appears to be a key demand driver because owners are investing more in specialized care. - In October 2023, the North American Pet Health Insurance Association reported U.S. companion-animal spending of $136.8 billion in 2022 and projected $143.6 billion in 2023. - The report’s emphasis on artificial intelligence and diagnostic integration suggests compounding is moving toward more data-driven, individualized treatment planning. - Growth in livestock applications indicates the market is not limited to companion animals.

What’s next: - The market is expected to keep expanding as veterinarians and compounders adopt more personalized formulations. - Broader use of injectable and oral compounded products could widen the category’s practical reach. - Regional competition is likely to intensify as the market grows across North America, Europe, Asia and other regions.

The bottom line: - Animal drug compounding is moving from a niche service to a larger veterinary care category, with personalized medicine and pet spending pushing steady global growth.